![](https://cannabis.net/drive/1000/3743_X5fO_fixdruglaws.jpg?width=200&height=200)
The DEA’s rejection of rescheduling leaves America at a crossroads. Do we continue allowing an agency with a vested interest in maintaining cannabis prohibition to override scientific evidence on the plant’s medical value? Or do we re-evaluate the necessity of the DEA’s existence altogether?